HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valtteri Julkunen Selected Research

Atrophy

12/2021A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valtteri Julkunen Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2010
3Cognitive Dysfunction
01/2023 - 01/2010
3Dementia (Dementias)
01/2020 - 01/2010
1Atrophy
12/2021
1Normal Pressure Hydrocephalus
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2020
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Neurobehavioral Manifestations
01/2020
1Frontotemporal Dementia (Semantic Dementia)
01/2020
1Cerebral Cortical Thinning
01/2010

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2020
1Pemetrexed (MTA)FDA Link
12/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1CholesterolIBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2010
1Apolipoprotein E4IBA
01/2010